| Literature DB >> 28865434 |
Yu-Hsuan Lin1,2, Min-Hua Jen3, Kuo-Liong Chien4.
Abstract
BACKGROUND: Evidence of an association between low socioeconomic position (SEP) and inflammatory markers is scant. This study aimed to examine how life-course SEP predicted C-reactive protein (CRP) and interleukin (IL-6) in older age from a national cohort.Entities:
Keywords: Inflammation; Life-course; Socioeconomic position
Mesh:
Substances:
Year: 2017 PMID: 28865434 PMCID: PMC5581430 DOI: 10.1186/s12877-017-0598-x
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Characteristics of SEBAS study population by childhood, young adulthood, active professional and older-age SEP
| Variable | Childhood SEP | Young adulthood SEP | Active professional life | Older age SEP | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Low | Med | High | pa | Low | Med | High | p | Low | Med | High | p | Low | Med | High |
|
| 466 | 168 | 398 | 268 | 381 | 380 | 180 | 446 | 410 | 456 | 307 | 237 | |||||
| Social Demographic Variables | ||||||||||||||||
| Mean age, in year | 66.7 | 66.7 | 63.1 | <.001 | 71.1 | 64.1 | 62.5 | <.001 | 71.8 | 64.8 | 62.9 | <.001 | 65.7 | 65.1 | 63.7 | 0.03 |
| (SD) | (9.1) | (10.5) | (9.3) | (8.8) | (8.8) | (9.1) | (8.6) | (9.0) | (9.2) | (9.2) | (9.4) | (9.8) | ||||
| Women, % | 47.0 | 50.9 | 44.0 | <.001 | 67.1 | 43.5 | 33.6 | <.001 | 74.3 | 46.0 | 32.8 | <.001 | 42.3 | 53.9 | 43.2 | <.01 |
| Low childhood SEP, % | 75.3 | 53.0 | 19.4 | <.001 | 76.4 | 56.7 | 21.4 | <.001 | 55.0 | 47.1 | 31.5 | <.001 | ||||
| Low young adulthood SEP, % | 42.7 | 23,9 | 8.1 | <.001 | 100 | 18.8 | 0.7 | <.001 | 33.1 | 23.6 | 14.0 | <.001 | ||||
| Low active professional SEP, % | 29.4 | 15.0 | 5.3 | <.001 | 68.0 | 0.0 | 0.0 | <.001 | 21.3 | 16.1 | 10.0 | <.001 | ||||
| Low older age SEP, % | 53.8 | 46.6 | 36.5 | <.001 | 59.4 | 53.0 | 29.6 | <.001 | 59.5 | 47.2 | 44.3 | <.001 | ||||
| Physiological marker | ||||||||||||||||
| Hypertension: SBP > 140 mmHg or DBP > 90 mmHg or using anti-hypertensive medication, % | 50.0 | 48.0 | 46.2 | 0.43 | 60.1 | 45.3 | 43.1 | <.001 | 56.4 | 57.4 | 54.2 | 0.92 | 48.7 | 46.5 | 46.3 | 0.14 |
| High total cholesterol: > = 240 mg/dL or using anti-hyperlipidemia medication, % | 17.1 | 24.2 | 2.1 | 0.30 | 17.2 | 18.4 | 21.1 | 0.56 | 18.2 | 17.0 | 22.4 | 0.28 | 18.7 | 18.5 | 21.7 | 0.08 |
| Low high-density lipoprotein (HDL) cholesterol: < 40 mg/dL, % | 18.6 | 15.6 | 15.1 | 0.27 | 19.8 | 16.3 | 15.6 | 0.59 | 21.1 | 16.5 | 15.2 | 0.09 | 17.8 | 16.5 | 16.4 | 0.95 |
| C-reactive protein (CRP, mg/dL), Mean | 0.17 | 0.18 | 0.15 | 0.20 | 0.18 | 0.19 | 0.14 | <.001 | 0.17 | 0.19 | 0.14 | <.001 | 0.17 | 0.16 | 0.14 | 0.01 |
| (SD) | (0.3) | (0.2) | (0.2) | (0.3) | (0.3) | (0.2) | (0.3) | (0.3) | (0.2) | (0.3) | (0.2) | (0.2) | ||||
| Interleukin-6 (IL-6, pg/mL), Mean | 3.2 | 3.3 | 2.9 | 0.17 | 4.0 | 3.2 | 3.0 | <.001 | 3.9 | 3.3 | 3.2 | 0.02 | 3.4 | 3.3 | 3.0 | 0.28 |
| (SD) | (3.5) | (3.5) | (3.1) | (3.4) | (3.0) | (2.8) | (3.5) | (2.8) | (3.1) | (3.2) | (2.9) | (2.8) | ||||
| Behavioral Risk Factor | ||||||||||||||||
| Current smoker, % | 20.6 | 16.6 | 18.5 | 0.49 | 13.5 | 23.1 | 19.3 | <.01 | 8.5 | 23.0 | 20.0 | <.01 | 22.8 | 16.0 | 16.8 | 0.05 |
| Frequent or daily drinking,% | 7.0 | 8.0 | 3.8 | <.001 | 4.2 | 8.7 | 4.5 | <.001 | 4.3 | 7.6 | 4.8 | <.001 | 7.9 | 4.5 | 3.8 | <.01 |
| Less than five servings of vegetable and fruit per day, % | 53.8 | 59.5 | 46.2 | <.01 | 56.2 | 58.2 | 41.6 | <.001 | 55.3 | 57.9 | 42.7 | <.001 | 59.6 | 47.5 | 38.9 | <.001 |
| Exercise less than 3 times per week, % | 55.4 | 53.9 | 54.1 | <.01 | 63.7 | 55.9 | 46.3 | <.001 | 65.0 | 57.0 | 46.6 | <.001 | 62.6 | 50.4 | 41.4 | <.001 |
| Obesity(BMI > = 27) | 26.4 | 27.6 | 23.3 | 0.09 | 27.6 | 28.4 | 20.6 | 0.03 | 25.9 | 28.7 | 21.2 | 0.05 | 25.0 | 26.6 | 24.0 | 0.17 |
| Psychosocial Factor | ||||||||||||||||
| Depressive symptoms % | 17.6 | 19.2 | 11.8 | 0.03 | 26.9 | 13.0 | 10.3 | <.001 | 26.1 | 15.8 | 10.4 | <.001 | 22.2 | 13.9 | 5.4 | <.001 |
| Perceived Stress (average score 0–4), Mean | 3.0 | 2.9 | 2.0 | 0.20 | 2.9 | 3.0 | 3.0 | 0.08 | 2.9 | 3.0 | 3.0 | 0.13 | 2.9 | 3.0 | 3.2 | <.001 |
| (SD) | (0.6) | (0.7) | (0.6) | (0.7) | (0.6) | (0.6) | (0.7) | (0.6) | (0.6) | (0.7) | (0.7) | (0.5) | ||||
a: p-value of ANOVA test for continuous variables and p-value of chi-square test for categorical variables
Fig. 1Group-based trajectories of life-course SEP. BIC = −2094.78 (3900 observations); BIC = −2088.60 (988 persons). Group 1, Low-Low (36.5%); Group 2, Low-High (26.8%); Group 3, High-High (36.7%)
Fig. 2Multiple adjusted mean concentrations of CRP and IL-6 by groups of life-course SEP
Covariates adjusted for the estimation of mean concentrations of life-course SEP include disease, BMI, Framingham risk score, health behavior (alcohol drinking, diet, and exercise), and depression. a CRP. b IL-6
Multivariable linear regression of life-course SEP groups
| CRP(ln mg/dL) | IL-6 (ln pg/mL) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEP (Ref: Low-Low) | SEP (Ref: Low-Low) | |||||||||||
| Low-high | High-High | Low-High | High-High | |||||||||
|
| (95% CI) | p |
| (95% CI) | p |
| (95% CI) | p |
| (95% CI) | p | |
| Model 1 | −0.059 | (−0.219, 0.102) | 0.47 |
|
|
| −0.025 | (−0.136, 0.086) | 0.66 |
|
|
|
| Model 2 | −0.060 | (−0.219, 0.100) | 0.46 |
|
|
| −0.017 | (−0.127, 0.093) | 0.76 |
|
|
|
| Model 3 | −0.052 | (−0.209, 0.105) | 0.52 |
|
|
| 0.002 | (−0.106, 0.111) | 0.97 |
|
|
|
| Model 4 | −0.038 | (−0.196, 0.120) | 0.63 |
|
|
| 0.009 | (−0.100, 0.118) | 0.88 |
|
|
|
| Model 5 | −0.022 | (−0.181, 0.137) | 0.79 |
|
|
| 0.018 | (−0.091, 0.128) | 0.75 |
|
|
|
| Model 6 | −0.032 | (−0.193, 0.128) | 0.69 |
|
|
| 0.017 | (−0.093, 0.128) | 0.76 |
|
|
|
| Model 7 | −0.044 | (−0.186, 0.098) | 0.54 |
|
|
| 0.028 | (−0.070, 0.126) | 0.58 | −0.040 | (−0.135, 0.055) | 0.41 |
Values of CRP and IL-6 were log transformed to adjust for their skewed and wide distributions
Bold values denote where the 95% confidence intervals (95% CIs) encompass the reference category
Model 1: Adjusted for age, gender, and disease
Model 2: Adjusted for covariates in Model 1 and BMI
Model 3: Adjusted for covariates in Model 2 and Framingham risk score
Model 4: Adjusted for covariates in Model 3 and health behavior (alcohol drinking, diet, and exercise)
Model 5: Adjusted for covariates in Model 4 and depression
Model 6: Adjusted for covariates in Model 5 and stress
Model 7: Adjusted for covariates in Model 6 and the other inflammatory marker